BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
Anand Rathi Recomends 'Buy' On Aarti Drugs
According to Anand Rathi, favourable macro and government initiatives are likely to lead to a strong momentum in API volumes for Aarti Drugs. The growth trend in export formulations is likely to continue for a few quarters as the company has ventured into newer regions, the brokerage adds.